Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic
population. Both experimental and clinical evidence suggest that diabetic subjects are …

ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …

Background Cardiotoxicity is a well-recognised complication of chemotherapy with
anthracycline and/or trastuzumab, and its prevention remains an important challenge in …

This is a metaanalysis of all available studies as of December 1990 that have evaluated the
effect of antihypertensive pharmacologic therapy on left ventricular structure examined by …

▪ Abstract This review discusses the rapidly progressing field of cardiomyocyte signal
transduction and the regulation of the hypertrophic response. When stimulated by a wide …

A ngiotensin-converting enzyme (ACE) inhibitors are commonly used drugs in the
management of a variety of cardiovascular diseases. They are effective antihypertensive …

Objective To compare the efficacy of indapamide sustained release (SR) 1.5 mg and
enalapril 20 mg at reducing left ventricular mass index (LVMI) in hypertensive patients with …

OBJECTIVES We examined the effect of long-term treatment with two doses of the
angiotensin converting enzyme (ACE) inhibitor enalapril on various immunological variables …

Synopsis: Enalapril maleate 1 is an orally active angiotensin-converting enzyme inhibitor. It
lowers peripheral vascular resistance without causing an increase in heart rate. Enalapril 10 …

Cardiac phenotypic modulation and remodeling appear to be involved in the
pathophysiology of cardiac hypertrophy and heart failure. We undertook this study to …